Is a complete CSE/MDMA research report available?

No complete published report is available for cse/MDMA (CSE/MDMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/MDMA (CSE/MDMA)

Canadian Securities Exchange: CSE/MDMA · CAD

CA$0.27

+0.03 (+12.8%)· Recorded snapshot

Market cap	25.7M
Revenue (ttm)	1.3M
Net income (ttm)	-1.6M
EPS (ttm)	-CA$0.02
Shares out	109.2M
Volume	87,839
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -1.6M
EPS (ttm): -CA$0.02
Market cap: 25.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-09 02:00 UTC

All CSE/MDMA indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CAD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 25.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA71719L1067
Last refreshed	2026-09-09
Market cap	CAD 25.7M
Price	CAD 0.27
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/MDMA
Website	https://pharmala.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.27%
EV/Sales	20.05x
FCF yield	-3.78%
P/B ratio	13.3x
P/S ratio	20.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-112.07%
EBITDA Margin	-111.57%
Gross margin	79.02%
Gross Profit	CAD 1M
Gross Profit Growth	81.86%
Gross Profit Growth Q	169.65%
Gross Profit Growth3 Y	115.24%
Net Income	CAD -1.6M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-126.87%
Profit Margin	-126.87%
ROA	-26.5
ROCE	-73.61
ROE	-68.66
ROIC	-37.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	141.05%
Cagr3y	4.09%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	201.24x
Revenue Growth Q	279.7x
Revenue Growth Qo Q	82.92x
Revenue Growth Quarters	4x
Revenue Growth Years	0x
Revenue Growth3 Y	132.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.38
Assets	CAD 3.1M
Cash	CAD 249,143
Current Assets	CAD 1.3M
Current Liabilities	CAD 1.1M
Debt	CAD 0
Equity	CAD 1.9M
Liabilities	CAD 1.1M
Long Term Assets	CAD 1.7M
Long Term Liabilities	CAD 0
Net Cash	CAD 249,143
Net Cash By Market Cap	CAD 0.97
Net Cash Growth	-79.99%
Net Debt Equity	CAD -0.13
Tangible Book Value	CAD 195,190
Tangible Book Value Per Share	CAD 0
WACC	8.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Inventory Turnover	0.54
Net Working Capital	CAD -56,120
Quick ratio	0.64
Working Capital	CAD 193,023
Working Capital Turnover	CAD 2.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	140.91%
200-day SMA	0.13
3Y total return	12.77%
50-day SMA	0.18
50-day SMA vs 200-day SMA	50over200
All Time High	0.54
All Time High Change	-50.93%
All Time High Date	2023-05-02
All Time Low	0.02
All Time Low Change	1,225%
All Time Low Date	2022-05-11
ATR	0.02
Beta	0.84
Beta1y	-0.45
Beta2y	0.6
Ch YTD	140.9
High	0.27
High52	0.29
High52 Date	2026-08-21
High52ch	-8.62%
Low	0.25
Low52	0.09
Low52 Date	2026-04-09
Low52ch	211.77%
Ma50ch	49.55%
Price vs 200-day SMA	97.91%
RSI	68.46
RSI Monthly	63.96
RSI Weekly	70.63
Sharpe ratio	1.2x
Sharpe Ratio3y	0.61x
Sortino ratio	2.62
Sortino Ratio3y	1.14
Total Return	-8.69%
Tr YTD	140.9
Tr1m	89.29%
Tr1w	15.22%
Tr3m	96.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,918,139%
Shares Insiders	9.27%
Shares Out	109,236,032
Shares Qo Q	0.14%
Shares Yo Y	8.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -1.6M
Adjusted OCF	-1,629,258
Average Volume	296,018.6x
Bv Per Share	0.02
CAPEX	CAD -2,918
Ch1m	89.29
Ch1w	15.22
Ch1y	140.9
Ch3m	96.3
Ch3y	12.77
Ch6m	140.9
Change	12.77%
Change From Open	1.92
Close	0.24
Days Gap	10.64
Depreciation Amortization	6,360
Dollar Volume	23,277.3
Earnings Date	2026-12-23
EBIT	CAD -1.4M
EBITDA	CAD -1.4M
EPS	CAD -0.02
F Score	2
FCF	CAD -971,445
FCF EV Yield	-3.82x
FCF Per Share	CAD -0.01
Financing CF	6,952
Fiscal Year End	August
Investing CF	925,313
Is Primary Listing	1
Last Earnings Date	2025-12-19
Last Report Date	2026-05-31
Ma150	0.14
Ma150ch	84.93%
Ma20	0.22
Ma20ch	18.83%
Net CF	-36,262
Next Earnings Date	2026-12-23
Open	0.26
Position In Range	100
Ppne	2,167
Price Date	2026-09-08
Ptbv Ratio	131.5
Relative Volume	0.3x
Revenue	1,267,632x
SBC By Revenue	52.12x
Share Based Comp	660,731
Tr6m	140.91%
Volume	87,839
Z Score	1.64

CSE/MDMA (CSE/MDMA)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/MDMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/MDMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/MDMA

Frequently asked questions